Clinical Trial Update: Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhidrosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pharmacokinetics, safety, tolerability, and clinical effect of topical umeclidinium for primary axillary hyperhidrosis. Results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperhidrosis

Drugs mentioned

• Umeclidinium (umeclidinium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hyperhidrosis | Phase 2 | Status: COMPLETED | Results posted: 2017-11-17